{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T19:01:43Z","timestamp":1773687703159,"version":"3.50.1"},"reference-count":22,"publisher":"Informa UK Limited","issue":"3","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005107","name":"Australasian Blistering Diseases Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2026,3,4]]},"DOI":"10.1080\/17512433.2026.2641138","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:52:11Z","timestamp":1772729531000},"page":"269-273","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the efficacy and tolerability of topical therapies for epidermolysis bullosa"],"prefix":"10.1080","volume":"19","author":[{"given":"Sophie","family":"Andreou","sequence":"first","affiliation":[{"name":"St George Hospital","place":["Sydney, Australia"]},{"name":"University of New South Wales","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sera","family":"Sarsam","sequence":"additional","affiliation":[{"name":"St George Hospital","place":["Sydney, Australia"]},{"name":"University of New South Wales","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"D\u00e9d\u00e9e F.","family":"Murrell","sequence":"additional","affiliation":[{"name":"St George Hospital","place":["Sydney, Australia"]},{"name":"University of New South Wales","place":["Sydney, Australia"]},{"name":"The George Institute for Global Health","place":["Sydney, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18921"},{"key":"e_1_3_4_4_1","first-page":"236","volume-title":"Epidermolysis Bullosa","author":"Welponer TB","year":"2021","unstructured":"Welponer TB, Laimer M. Treatment of skin disease: comprehensive therapeutic strategies. In: Lebwohl MGH, Coulson IH, Murrell DF, editors. Epidermolysis Bullosa. 6 ed. Elsevier; 2021. p. 236\u2013238.","edition":"6"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0210-0"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01737-y"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206663"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljac001"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-025-00942-y"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01419-3"},{"key":"e_1_3_4_11_1","first-page":"A59","article-title":"Allantoin 6% cream in epidermolysis bullosa: a case report","volume":"25","author":"Machin AGM","year":"2018","unstructured":"Machin AGM, Barrios JA, Cabrera M, et al. Allantoin 6% cream in epidermolysis bullosa: a case report. Eur J Hosp Pharm. 2018;25:A59.","journal-title":"Eur J Hosp Pharm"},{"issue":"220","key":"e_1_3_4_12_1","first-page":"32","article-title":"Diacerein 1% ointment for epidermolysis bullosa in a randomized controlled pilot study","volume":"100","author":"Huang CH","year":"2020","unstructured":"Huang CH, Lee JY, Hsu HL, et al. Diacerein 1% ointment for epidermolysis bullosa in a randomized controlled pilot study. Acta Derm Venereol. 2020;100(SUPPL 220):32.","journal-title":"Acta Derm Venereol"},{"issue":"220","key":"e_1_3_4_13_1","first-page":"46","article-title":"Diacerein 1% ointment for the treatment of epidermolysis bullosa simplex: results of a phase 2 study","volume":"100","author":"Teng J","year":"2020","unstructured":"Teng J, Paller AS, Bruckner AL, et al. Diacerein 1% ointment for the treatment of epidermolysis bullosa simplex: results of a phase 2 study. Acta Derm Venereol. 2020;100(SUPPL 220):46\u201347.","journal-title":"Acta Derm Venereol"},{"key":"e_1_3_4_14_1","unstructured":"Long term open-label study evaluating safety of diacerein 1% ointment topical formulation in subjects with epidermolysis bullosa simplex [internet]. ClinicalTrials.gov; 2026."},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.07.170"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.03.751"},{"key":"e_1_3_4_17_1","unstructured":"Teng J. Using topical sirolimus 2% for patients with epidermolysis bullosa simple (EBS) study ClinicalTrials.Gov. 2022."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04557.x"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-010-1131-8"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI92707"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.5992"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02062-2"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.5857"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75291-7"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2641138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:04:21Z","timestamp":1773684261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2026.2641138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,4]]}},"alternative-id":["10.1080\/17512433.2026.2641138"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2026.2641138","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}